CUBIST PHARMACEUTICALS INC 4

4 · CUBIST PHARMACEUTICALS INC · Filed Aug 20, 2014

Form 4

Period: 2014-08-19

SVP, Commercial Operations

Transactions

Exercise/Conversion
Common Stock
2014-08-19$21.56/sh+5,625$121,275→ 23,761 total
Exercise/Conversion
Common Stock
2014-08-19$42.09/sh+17,500$736,575→ 49,698 total
Exercise/Conversion
Common Stock
2014-08-19$34.80/sh+8,437$293,565→ 32,198 total
Exercise/Conversion
Common Stock
2014-08-19$41.60/sh+6,764$281,382→ 56,462 total
Exercise/Conversion
Stock Options (Right to Buy)
2014-08-19−5,625→ 0 total
Exercise: $21.56From: 2010-08-14Exp: 2020-05-14→ Common Stock (5,625 underlying)
Sale
Common Stock
2014-08-19$65.88/sh−38,326$2,524,852→ 18,136 total
Exercise/Conversion
Stock Options (Right to Buy)
2014-08-19−17,500→ 15,000 total
Exercise: $42.09From: 2012-05-16Exp: 2022-02-16→ Common Stock (17,500 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2014-08-19−8,437→ 8,438 total
Exercise: $34.80From: 2011-08-13Exp: 2021-05-13→ Common Stock (8,437 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2014-08-19−6,764→ 22,545 total
Exercise: $41.60From: 2013-05-15Exp: 2023-02-15→ Common Stock (6,764 underlying)

Holdings

Footnotes (3)

[F1]This transaction was executed in multiple trades at prices ranging from $65.80 to $66.135 The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
[F2]Option vests 6.25% quarterly over a four-year period.
[F3]Options vest 6.25% quarterly over a four-year period.

Documents

2 files